Johnson & Johnson
JNJ
$149.18
Share price
-0.49%
Change (1 day)
-9.60%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Market capitalization of Johnson & Johnson (JNJ)
Market cap: $359.02 Billion
As of May 2024 Johnson & Johnson has a market cap of $359.02 Billion. This makes Johnson & Johnson the world's 25th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Johnson & Johnson from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $359.02 B | -4.85% |
| 2023 | $377.31 B | -18.3% |
| 2022 | $461.84 B | 2.55% |
| 2021 | $450.35 B | 8.7% |
| 2020 | $414.30 B | 7.89% |
| 2019 | $384.00 B | 11.77% |
| 2018 | $343.57 B | -8.47% |
| 2017 | $375.36 B | 19.76% |
| 2016 | $313.43 B | 10.28% |
| 2015 | $284.22 B | -2.34% |
| 2014 | $291.04 B | 12.66% |
| 2013 | $258.34 B | 32.64% |
| 2012 | $194.77 B | 8.76% |
| 2011 | $179.08 B | 5.44% |
| 2010 | $169.85 B | -4.42% |
| 2009 | $177.71 B | 7.05% |
| 2008 | $166.00 B | -12.37% |
| 2007 | $189.44 B | -0.82% |
| 2006 | $191.01 B | 6.85% |
| 2005 | $178.76 B | -5.12% |
| 2004 | $188.42 B | 22.89% |
| 2003 | $153.32 B | -3.83% |
| 2002 | $159.42 B | -11.47% |
| 2001 | $180.09 B |
End of Day market cap according to different sources
On May 2nd, 2024 the market cap of Johnson & Johnson was reported to be:
$360.80 Billion
$360.80 Billion
$361.27 Billion
$361.19 Billion
$364.31 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $198.62 B | -44.68% | 🇨🇭 Switzerland |
 Pfizer PFE | $156.76 B | -56.34% | 🇺🇸 USA |
 Abbott Laboratories ABT | $184.22 B | -48.69% | 🇺🇸 USA |
 Medtronic MDT | $108.65 B | -69.74% | 🇮🇪 Ireland |
 Eli Lilly LLY | $703.70 B | 96.00% | 🇺🇸 USA |
 Sanofi SNY | $123.47 B | -65.61% | 🇫🇷 France |
 Gilead Sciences GILD | $80.66 B | -77.53% | 🇺🇸 USA |
 Stryker Corporation SYK | $125.43 B | -65.06% | 🇺🇸 USA |
 Merck MRK | $323.72 B | -9.83% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $88.79 B | -75.27% | 🇬🇧 UK |